Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy

The AAPS Journal
Jean-Michel Scherrmann

Abstract

The co-administration of hydroxychloroquine with azithromycin is proposed in COVID-19 therapy. We hypothesize a new mechanism supporting the synergistic interaction between these drugs. Azithromycin is a substrate of ABCB1 (P-glycoprotein) which is localized in endosomes and lysosomes with a polarized substrate transport from the cell cytosol into the vesicle interior. SARS-CoV-2 and drugs meet in these acidic organelles and both basic drugs, which are potent lysosomotropic compounds, will become protonated and trapped within these vesicles. Consequently, their intra-vesicular concentrations can attain low micromolar effective cytotoxic concentrations on SARS-CoV-2 while concomitantly increase the intra-vesicular pH up to around neutrality. This last effect inhibits lysosomal enzyme activities responsible in virus entry and replication cycle. Based on these considerations, we hypothesize that ABCB1 could be a possible enhancer by confining azithromycin more extensively than expected when the trapping is solely dependent on the passive diffusion. This additional mechanism may therefore explain the synergistic effect when azithromycin is added to hydroxychloroquine, leading to apparently more rapid virus clearance and better clin...Continue Reading

References

Jan 1, 1982·Acta Medica Scandinavica·I Leden
May 9, 2002·Drug Metabolism Reviews·Richard B Kim
Aug 20, 2003·Molecular Biology of the Cell·Asha Rajagopal, Sanford M Simon
Nov 1, 2003·The Lancet Infectious Diseases·Andrea SavarinoRoberto Cauda
Jul 19, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Rose HayeshiAnna-Lena B Ungell
May 15, 2008·PLoS Neglected Tropical Diseases·Ahmed El-TahtawyCharles A Knirsch
Jul 14, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Vesna MunićVesna Eraković Haber
Jan 26, 2011·Proceedings of the National Academy of Sciences of the United States of America·Pavitra KannanMatthew D Hall
May 10, 2011·The Lancet Infectious Diseases·Andrea Savarino
Jul 9, 2011·Expert Opinion on Drug Metabolism & Toxicology·R Matthew Chico, Daniel Chandramohan
Jan 4, 2012·The International Journal of Biochemistry & Cell Biology·Dong Fu, Irwin M Arias
Oct 27, 2012·Cellular Immunology·Krunoslav NujićVesna Eraković Haber
Feb 5, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Faraz KazmiAndrew Parkinson
Sep 3, 2013·Biological & Pharmaceutical Bulletin·Kohei TogamiKazuhiro Morimoto
Sep 26, 2013·The Journal of Biological Chemistry·Tetsuo YamagishiDes R Richardson
Oct 3, 2013·The Journal of Clinical Investigation·Piet Borst, Alfred H Schinkel
Aug 26, 2014·Journal of Pharmacological and Toxicological Methods·Xiannu JinBrandon S Pybus
Sep 15, 2014·Malaria Journal·Sanna R RijpmaJan B Koenderink
Jun 10, 2015·Biochimica Et Biophysica Acta·Kazuhiro KatayamaSuresh V Ambudkar
Jul 10, 2015·ACS Infectious Diseases·Peter B MadridMary J Tanga
Apr 12, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mariline GameiroFernando Remião
Nov 28, 2017·Antiviral Research·Yong Wah TanJustin Jang Hann Chu
Aug 21, 2018·Traffic·Fengjuan WangPatricia Boya
Sep 4, 2019·Nature Reviews. Drug Discovery·Srinivasa Reddy BonamSylviane Muller
Mar 10, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Xueting YaoDongyang Liu
Mar 17, 2020·International Journal of Antimicrobial Agents·Christian A DevauxDidier Raoult
Mar 21, 2020·The Journal of Antimicrobial Chemotherapy·Dan ZhouQiang Tong
Mar 25, 2020·International Journal of Antimicrobial Agents·Philippe GautretDidier Raoult
Apr 7, 2020·Bioscience Trends·Masashi OheHouman Goudarzi
Apr 15, 2020·Clinical Pharmacology and Therapeutics·Maria Garcia-CremadesRadojka M Savic

❮ Previous
Next ❯

Citations

Sep 24, 2020·PloS One·Haroldo V RibeiroQuentin S Hanley
Aug 18, 2020·Clinical Pharmacology and Therapeutics·Jean-Michel Scherrmann
Jan 20, 2021·Pulmonary Pharmacology & Therapeutics·Juan Ignacio Morán BlancoKarina Villar Gómez de Las Heras
Mar 2, 2021·Journal of Clinical Pharmacy and Therapeutics·Pascal Le Corre, Gwenolé Loas
Mar 26, 2021·Frontiers in Pharmacology·Omkar IndariHem Chandra Jha
Apr 4, 2021·Viruses·Ingrid Fricke-Galindo, Ramcés Falfán-Valencia
Oct 16, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Awortwe Charles, Cascorbi Ingolf
Sep 7, 2021·International Reviews of Immunology·Ying LuoYan Xu

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Internal and Emergency Medicine
Alice FaninGruppo di Autoformazione Metodologica (GrAM)
The New England Journal of Medicine
Rahul ChoudharyDeepak Kumar
© 2022 Meta ULC. All rights reserved